From Gene-Edited Embryos to Covid: China Faces Regulatory and Ethical Challenges
By Yuting Zhu and Jonathan D. Moreno,
The Hastings Center
| 07. 28. 2022
In early April, He Jiankui, the Chinese scientist who used gene-editing technology on human embryos born in 2018, was released from his three-year prison sentence, imposed after a Shenzhen District Court convicted him of “illegal medical practice.” He and two accomplices were banned from conducting any work related to assisted reproductive technology, applying for administrative permits for research on human genetic resources, and from applying for research funds.
The He Jiankui affair and, little more than a year later, the Covid pandemic have focused attention in China on ethical governance of research and medical practice. Over the last two years, China has updated some regulations on human genetic engineering and assisted reproduction and established a national committee to guide and supervise bioethics nationwide. But there are legal gaps in some of the regulations and tension between competing values: the desire to encourage new research and to potentially inhibit it by imposing stricter ethics regulations.
An example of this tension came out in public expression over He Jiankui. Ever since his arrest there have been occasional comments on Chinese social media...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...